Payer Perceptions and Utilization of ICER Value Assessment Framework

By Xcenda |
Insights Home
Xcenda examines the impact of the ICER value assessment framework on payer perceptions.
Topics:
Commercialization Market Access

Related Content

HTA Quarterly | Fall 2019

Inverted color AmerisourceBergen icon
Xcenda
October 2019

Manufacturers

Biosimilars: Launch Insights From the Field

Melissa Mulchahey
Xcenda
September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

HTA Quarterly | Summer 2019

Inverted color AmerisourceBergen icon
Xcenda
August 2019